Worldwide News

Do you want to learn about: Trained immunity The role of epigenetic targets in trained immunity Hit discovery through ultra-high throughput screening of large libraries Industry standard Hit-to-Lead biological profiling frameworks Join Dr. Saman Honarnejad, Director Drug Discovery at Pivot Park Screening Centre​ on 14 December 3PM (GMT) for this webinar in which he will […]

An international team comprising researchers from the University of Bristol, and Hunan and Central South Universities in China, have prepared biocompatible protocells that generate nitric oxide gas – a known reagent for blood vessel dilation – that when placed inside blood vessels expand the biological tissue. In a new study published today in Nature Chemistry, […]

The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the US Department of Energy’s (DOE) Argonne National Laboratory. The team was singled out for its work, ​AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics, which shines […]

Scientists from the University of Oxford, working as part of the EBOVAC2 EBL2001 study group, have announced the results of a Phase II trial of a replication-deficient adenovirus vaccine aimed at providing protection against the lethal Ebola virus. Writing in the journal Lancet: Infectious Diseases, they conclude that the two-dose vaccine has a good safety […]

A new drug had been developed which can be applied to the skin to help prevent organ transplant recipients from developing harmful skin cancers. The world-first treatment being developed at The University of Queensland is said to be the only drug of its type that could prevent the incidence of skin cancers for transplant patients. […]

The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The data, published today in The Lancet, suggest that one of the groups most vulnerable to serious illness, and death from COVID-19, could […]

MOBILion Systems is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease (PD). The project is funded by a grant from The Michael J. Fox Foundation and its partner the Shake It Up Australia […]

New research has shown that the antidepressant sertraline helps to inhibit the growth of cancer cells. The substance acts on a metabolic addiction that allows different types of cancer to grow. This is shown by a study on cell cultures and lab animals performed by various research labs of KU Leuven. Their findings were published […]

Lantern Pharma has reached a significant milestone by surpassing one billion curated data points on its RADR platform, a total it believes is the most amassed by any company in the biotech sector. The milestone, which was reached well ahead of schedule, enables new opportunities in Lantern’s work to identify and suggest combination cancer therapy programs, […]

Pfizer and BioNTech have announced that after conducting the final efficacy analysis in their ongoing Phase III study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study’s primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% in participants without prior SARS-CoV-2 infection (first primary objective) and also in […]